Clinical Trials

Showing trials with last updates posted in 2024.

NCT04807166 | ACTIVE_NOT_RECRUITING | PHASE2
56 participants

Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2024-07-03
Start Date:
2021-08-24
Completion:
2025-09-30
Conditions
  • Ovarian Neoplasms
  • Fallopian Tube Neoplasms
  • Neoplasms by Site
  • Genital Neoplasms, Female
  • Neoplasms, Glandular and Epithelial
  • Neoplasms by Histologic Type
  • Carcinoma, Ovarian Epithelial
  • Ovarian Diseases
  • Genital Diseases, Female
  • Endocrine System Diseases
  • Carcinoma
  • Anlotinib
  • Angiogenesis
  • Antineoplastic Agents
  • Tyrosine Kinase Inhibitor
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page